{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:56:41Z","timestamp":1790121401810,"version":"4.0.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.pbb.2009.01.015","type":"journal-article","created":{"date-parts":[[2009,1,27]],"date-time":"2009-01-27T04:48:23Z","timestamp":1233031703000},"page":"199-205","source":"Crossref","is-referenced-by-count":70,"title":["Immunopharmacotherapy: Vaccination strategies as a treatment for drug abuse and dependence"],"prefix":"10.1016","volume":"92","author":[{"given":"Amira Y.","family":"Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim D.","family":"Janda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2009.01.015_bib1","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0022-3565(24)39014-7","article-title":"Natural and artificial enzymes against cocaine. I: Monoclonal antibody 15A10 and the reinforcing effect of cocaine in rats","volume":"295","author":"Baird","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2009.01.015_bib2","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1126\/science.178.4067.1290","article-title":"Evidence for active immunity to morphine in mice","volume":"178","author":"Berkowitz","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.pbb.2009.01.015_bib3","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/252708a0","article-title":"Changes in heroin self-administration by a rhesus monkey after morphine immunisation","volume":"252","author":"Bonese","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2009.01.015_bib4","first-page":"58","article-title":"Development of vaccines to help treat drug dependence","author":"Bunce","year":"2003","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.pbb.2009.01.015_bib5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/378727a0","article-title":"Suppression of psychoactive effects of cocaine by active immunization","volume":"378","author":"Carrera","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2009.01.015_bib6","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.1073\/pnas.97.11.6202","article-title":"Cocaine vaccines: antibody protection againste relapse in a rat model","volume":"97","author":"Carrera","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pbb.2009.01.015_bib7","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1073\/pnas.041610998","article-title":"A second-generation vaccine protects against the psychoactive effects of cocaine","volume":"98","author":"Carrera","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pbb.2009.01.015_bib8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bmc.2003.11.029","article-title":"Investigations using immunization to attenuate the psychoactive effects of nicotine","volume":"12","author":"Carrera","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pbb.2009.01.015_bib9","doi-asserted-by":"crossref","first-page":"10416","DOI":"10.1073\/pnas.0403795101","article-title":"Treating cocaine addiction with viruses","volume":"101","author":"Carrera","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pbb.2009.01.015_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.pbb.2005.04.018","article-title":"Evaluation of the anticocaine monoclonal antibody GNC92H2 as an immunotherapy for cocaine overdose","volume":"81","author":"Carrera","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2009.01.015_bib11","series-title":"Celtic Pharma reports preliminary results of phase 2 clinical trials with TA-CD, cocaine addiction vaccine","author":"Celtic Pharma","year":"2006"},{"key":"10.1016\/j.pbb.2009.01.015_bib12","unstructured":"Celtic Pharma TA CD. Retrieved September 23, 2008, from http:\/\/www.celticpharma.com\/theportfolio\/ta-cd.html."},{"key":"10.1016\/j.pbb.2009.01.015_bib13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000067433","article-title":"Preclinical development of a vaccine \u201cagainst smoking\u201d","volume":"25","author":"Cerny","year":"2002","journal-title":"Onkologie"},{"key":"10.1016\/j.pbb.2009.01.015_bib14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJM198509123131105","article-title":"Cocaine use in pregnancy","volume":"313","author":"Chasnoff","year":"1985","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pbb.2009.01.015_bib15","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.2174\/0929867043364270","article-title":"Exploring ramachandran and chi space: conformationally constrained amino acids and peptides in the design of bioactive polypeptide ligands","volume":"11","author":"Cowell","year":"2004","journal-title":"Current Med Chem"},{"key":"10.1016\/j.pbb.2009.01.015_bib16","unstructured":"Cytos Biotechnology Clinical Development CYT002-NicQb. (2006). Retrieved June 30, 2008, from http:\/\/www.cytos.com\/doc\/NicQb_June06_E_fv.pdf."},{"key":"10.1016\/j.pbb.2009.01.015_bib18","series-title":"EMCDDA Literature reviews - Treatment of problem cocaine use: a review of the literature","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2007"},{"key":"10.1016\/j.pbb.2009.01.015_bib19","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nm1096-1129","article-title":"Efficacy of a therapeutic cocaine vaccine in rodent models","volume":"2","author":"Fox","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.pbb.2009.01.015_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrmicro1681","article-title":"The perfect mix: recent progress in adjuvant research","volume":"5","author":"Guy","year":"2007","journal-title":"Nature Rev Microbio"},{"key":"10.1016\/j.pbb.2009.01.015_bib21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.clpt.2005.08.007","article-title":"Safety and immunogenicity of a nicotine conjugate vaccine in current smokers","volume":"78","author":"Hatsukami","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pbb.2009.01.015_bib22","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0022-3565(24)37155-1","article-title":"Active immunization alters the plasma nicotine concntration in rats","volume":"283","author":"Hieda","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2009.01.015_bib23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0192-0561(00)00042-4","article-title":"Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain","volume":"22","author":"Hieda","year":"2000","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.pbb.2009.01.015_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/tc.12.1.21","article-title":"A meta-analysis of the efficacy of over-the-counter nicotine replacement","volume":"12","author":"Hughes","year":"2003","journal-title":"Tob Control"},{"key":"10.1016\/j.pbb.2009.01.015_bib25","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1016\/j.bmcl.2007.05.032","article-title":"Positional linker effects in haptens for cocaine immunopharmacotherapy","volume":"17","author":"Ino","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pbb.2009.01.015_bib26","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1021\/jo001442w","article-title":"An immunotherapeutic program for the treatment of nicotine addiction: hapten design and synthesis","volume":"66","author":"Isomura","year":"2001","journal-title":"J Org Chem"},{"key":"10.1016\/j.pbb.2009.01.015_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an a4b2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial","volume":"296","author":"Jorenby","year":"2006","journal-title":"J Amer Med Assoc"},{"key":"10.1016\/j.pbb.2009.01.015_bib28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2165\/00003495-200363040-00001","article-title":"Vaccines against drugs of abuse: a viable treatment option?","author":"Kantak","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.pbb.2009.01.015_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s002130050049","article-title":"Evalutaion of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model","volume":"148","author":"Kantak","year":"2000","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.pbb.2009.01.015_bib30","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nrn2234","article-title":"Synaptic plasticity and addiciton","author":"Kauer","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pbb.2009.01.015_bib31","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1124\/jpet.102.046805","article-title":"Maternal vaccination against nicotine reduces nicotine distribution to fetal brain in rats","volume":"305","author":"Keyler","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2009.01.015_bib32","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1124\/dmd.105.004234","article-title":"Monoclonoal nicotine-specific antibodies reduce nicotine distribution to brain in rats: dose and affinity response relationship","volume":"33","author":"Keyler","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pbb.2009.01.015_bib33","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.intimp.2008.07.001","article-title":"Enhanced immunogenicity of a bivalent nicotine vaccine","volume":"8","author":"Keyler","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pbb.2009.01.015_bib34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.278.5335.52","article-title":"Drug abuse: hedonic homeostatic dysregulation","volume":"278","author":"Koob","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.pbb.2009.01.015_bib35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pharmthera.2005.06.009","article-title":"Immunotherapy for the treatment of drug abuse","author":"Kosten","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pbb.2009.01.015_bib36","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0264-410X(01)00425-X","article-title":"Human therapeutic cocaine vaccine: safety and immunogenicity","volume":"20","author":"Kosten","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.pbb.2009.01.015_bib37","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1126\/science.8456315","article-title":"Antibody-catalyzed degradation of cocaine","volume":"259","author":"Landry","year":"1993","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pbb.2009.01.015_bib38","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.1208\/aapsj080108","article-title":"Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies","volume":"8","author":"Le Sage","year":"2006","journal-title":"AAPS J"},{"key":"10.1016\/j.pbb.2009.01.015_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0091-3057(00)00436-6","article-title":"Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome","volume":"68","author":"Malin","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2009.01.015_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0960-894X(00)00659-4","article-title":"Cocaine catalytic antibodies: the primary importance of linker effects","volume":"11","author":"Matsushita","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pbb.2009.01.015_bib41","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/eji.200526285","article-title":"A therapeutic vaccine for nicotine dependece: preclinical efficacy and Phase I safety and immunogenicity","volume":"35","author":"Maurer","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pbb.2009.01.015_bib42","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jmb.2006.10.031","article-title":"Identification and characterization of single chain anti-cocaine catalytic antibodies","volume":"365","author":"McKenzie","year":"2007","journal-title":"J Mol Biol"},{"key":"10.1016\/j.pbb.2009.01.015_bib43","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1021\/ja034805t","article-title":"A new strategy for improved nicotine vaccines using conformationally constrained haptens","volume":"125","author":"Meijler","year":"2003","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pbb.2009.01.015_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/1570163043484851","article-title":"Development of Immunopharmacotherapy against drugs of abuse","volume":"1","author":"Meijler","year":"2004","journal-title":"Curr Drug Discov Technol"},{"key":"10.1016\/j.pbb.2009.01.015_bib45","doi-asserted-by":"crossref","first-page":"10176","DOI":"10.1073\/pnas.95.17.10176","article-title":"A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats","volume":"95","author":"Mets","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pbb.2009.01.015_bib46","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/jama.291.10.1238","article-title":"Actual causes of death in the United States","volume":"291","author":"Mokdad","year":"2004","journal-title":"J Amer Med Assoc"},{"key":"10.1016\/j.pbb.2009.01.015_bib47","unstructured":"Nabi Biopharmaceutical Clinical Trial Information. (2007). Retrieved June 30, 2008, from http:\/\/www.nabi.com\/pipeline\/clinicaltrials.php#3."},{"key":"10.1016\/j.pbb.2009.01.015_bib48","series-title":"NIDA research report-cocaine abuse and addiction","author":"National Institute on Drug Abuse","year":"2004"},{"key":"10.1016\/j.pbb.2009.01.015_bib49","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.bcp.2005.08.013","article-title":"Effects of nicotine-specfiic antibodies, Nic311 and Nic-IgG, on the transfer of nicotine across the human placenta","volume":"70","author":"Nekhayeva","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2009.01.015_bib50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0091-3057(99)00206-3","article-title":"A nicotine-conjugate vaccine reduces nicotine distribution to brian and attenuates its behavioral and cardiovascular effects in rats","volume":"65","author":"Pentel","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2009.01.015_bib51","first-page":"1","article-title":"The treatment of cocaine abuse: problems and perspectives","author":"Preti","year":"2006","journal-title":"Cocaine and Heroin Abuse Research"},{"key":"10.1016\/j.pbb.2009.01.015_bib52","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/bit.10598","article-title":"Expression and characterization of a humanized cocaine-binding antibody","volume":"82","author":"Redwan","year":"2003","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.pbb.2009.01.015_bib53","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1124\/jpet.107.135111","article-title":"Combined active and passive immunization enhances the efficacy of immunotherapy against nicotine in rats","volume":"325","author":"Roiko","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2009.01.015_bib54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1567-5769(02)00260-6","article-title":"Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant","volume":"3","author":"Sanderson","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pbb.2009.01.015_bib55","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2567.2000.00004.x","article-title":"Exploring the feasibility of anti-idiotypic cocaine vaccine: analysis of the specificity of anticocaine antibodies (Ab1) capable of inducing Ab2beta anti-idiotypic antibodies","volume":"100","author":"Schabacker","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.pbb.2009.01.015_bib56","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/jama.287.15.1952","article-title":"Cognititve and motor outcomes of cocaine-exposed infants","volume":"287","author":"Singer","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.pbb.2009.01.015_bib57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0022-3565(25)28956-X","article-title":"Quantitative determination of morphine in serum by radioimmunoassay","volume":"178","author":"Spector","year":"1971","journal-title":"J Pharm Exp Ther"},{"key":"10.1016\/j.pbb.2009.01.015_bib58","series-title":"Proceedings of the 9th Annual Meeting of the Society for Research on Nicotine and Tobacco","article-title":"Longitudinal safety and immunogenicity data of TA-NIC, a novel nicotine vaccine","author":"St Clair Roberts","year":"2003"},{"key":"10.1016\/j.pbb.2009.01.015_bib59","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1037\/1064-1297.9.2.228","article-title":"Inhibition of nicotine-induced seizures in rats by combining vaccination against nicotine with chronic nicotine infusion","volume":"9","author":"Tuncok","year":"2001","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2009.01.015_bib60","unstructured":"U.S. Department of Health and Human Services Center for Disease Control and Prevention. Retrieved June 30, 2008, from http:\/\/www.cdc.gov\/tobacco\/data_statistics\/fact_sheets\/cessation\/cessation2.htm."},{"key":"10.1016\/j.pbb.2009.01.015_bib61","series-title":"Results from the 2007 National Survey on Drug Use and Health: National Findings","author":"US Substance Abuse and Mental Health Services Administration","year":"2008"},{"key":"10.1016\/j.pbb.2009.01.015_bib62","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00004714-199502000-00010","article-title":"Cocaine abuse and dependence","volume":"15","author":"Withers","year":"1995","journal-title":"J Clinical Psychopharmacol"},{"key":"10.1016\/j.pbb.2009.01.015_bib63","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1021\/ja953077+","article-title":"Anti-cocaine catalytic antibodies: a synthetic approach to improve antibody diversity","volume":"118","author":"Yang","year":"1996","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pbb.2009.01.015_bib64","doi-asserted-by":"crossref","first-page":"12148","DOI":"10.1021\/ja803646t","article-title":"Most efficient cocaine hydrolase designed by virtual screening of transistion states","volume":"130","author":"Zheng","year":"2008","journal-title":"J Am Chem Soc"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305709000446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305709000446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T02:39:45Z","timestamp":1738895985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305709000446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0091305709000446"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2009.01.015","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}